Evidence map›Paper›PMID 34882498›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability.

N Lynn Henry, André Rogatko, Patricia A Ganz

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

N Lynn HenryN. Lynn Henry, MD, PhD, University of Michigan Rogel Cancer Center, Ann Arbor, MI; André Rogatko, PhD, Cedars Sinai Medical Center, Los Angeles, CA; and Patricia A. Ganz, MD, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.ORCID 0000-0002-4771-5930
André RogatkoN. Lynn Henry, MD, PhD, University of Michigan Rogel Cancer Center, Ann Arbor, MI; André Rogatko, PhD, Cedars Sinai Medical Center, Los Angeles, CA; and Patricia A. Ganz, MD, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.ORCID 0000-0001-8935-8890
Patricia A GanzN. Lynn Henry, MD, PhD, University of Michigan Rogel Cancer Center, Ann Arbor, MI; André Rogatko, PhD, Cedars Sinai Medical Center, Los Angeles, CA; and Patricia A. Ganz, MD, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.ORCID 0000-0002-1841-4143

Funding

Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical TrialsU01CA232859 · NCI · CEDARS-SINAI MEDICAL CENTER · PI GANZ, PATRICIA A., TIGHIOUART, MOURAD · 2018 to 2023
$3.7M
NCI NIH HHS U01 CA232859
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient Reported Outcome MeasuresHumans

Identifiers

PMID34882498
PMCPMC8797605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.